Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1973 Jan;32(1):53–57. doi: 10.1136/ard.32.1.53

Secondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti-IgM.

P V Shirodaria, K B Fraser, F Stanford
PMCID: PMC1006034  PMID: 4568349

Full text

PDF
53

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baublis J. V., Brown G. C. Specific response of the immunoglobulins to rubella infection. Proc Soc Exp Biol Med. 1968 May;128(1):206–210. doi: 10.3181/00379727-128-32979. [DOI] [PubMed] [Google Scholar]
  2. Chantler S., Haire M. Evaluation of the immunological specificity of fluorescein-labelled anti-human IgM conjugates. Immunology. 1972 Jul;23(1):7–12. [PMC free article] [PubMed] [Google Scholar]
  3. Connolly J. H., Haire M., Hadden D. S. Measles immunoglobulins in subacute sclerosing panencephalitis. Br Med J. 1971 Jan 2;1(5739):23–25. doi: 10.1136/bmj.1.5739.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FRANKLIN E. C., HOLMAN H. R., MULLER-EBERHARD H. J., KUNKEL H. G. An unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis. J Exp Med. 1957 May 1;105(5):425–438. doi: 10.1084/jem.105.5.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fraser K. B., Shirodaria P. V., Stanford C. F. Fluorescent staining and human IgM. Br Med J. 1971 Sep 18;3(5776):707–707. doi: 10.1136/bmj.3.5776.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GOODMAN J. W. Reaction of rheumatoid sera with fragments of papain-digested rabbit gamma globulin. Proc Soc Exp Biol Med. 1961 Apr;106:822–825. doi: 10.3181/00379727-106-26488. [DOI] [PubMed] [Google Scholar]
  7. HEIMER R., LEVIN F. M., KAHN M. F. INHIBITION OF COMPLEMENT FIXATION BY HUMAN SERUM. II. THE ACTIVITY OF A GAMMA-LM GLOBULIN AND RHEUMATOID FACTOR IN COMPLEMENT FIXATION REACTIONS. J Immunol. 1963 Dec;91:866–872. [PubMed] [Google Scholar]
  8. HEIMER R., LEVIN F. M., PRIMACK A., CORCOS J. M., NOSENZO C. Inhibition of complement fixation by human serum. J Immunol. 1962 Sep;89:382–390. [PubMed] [Google Scholar]
  9. Haire M., Hadden D. S. Immunoglobulin responses in rubella and its complications. Br Med J. 1970 Jul 18;3(5715):130–132. doi: 10.1136/bmj.3.5715.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Holborow E. J., Johnson G. D. The nature of antinuclear immunoglobulins. Ann N Y Acad Sci. 1965 Jun 30;124(2):833–837. doi: 10.1111/j.1749-6632.1965.tb19005.x. [DOI] [PubMed] [Google Scholar]
  11. MCCORMICK J. N., DAY J. THE ASSOCIATION OF RHEUMATOID FACTOR WITHANTINUCLEAR FACTOR ACTIVITY. Lancet. 1963 Sep 14;2(7307):554–556. doi: 10.1016/s0140-6736(63)92648-5. [DOI] [PubMed] [Google Scholar]
  12. Millar J. H., Fraser K. B., Haire M., Connolly J. H., Shirodaria P. V., Hadden D. S. Immunoglobulin M specific for measles and mumps in multiple sclerosis. Br Med J. 1971 May 15;2(5758):378–380. doi: 10.1136/bmj.2.5758.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stanford F. Comparison of complement-fixing antibody titres in patients with rheumatoid arthritis and matched controls. Ann Rheum Dis. 1972 Jul;31(4):330–333. doi: 10.1136/ard.31.4.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Waller M. The relationship between rheumatoid factors and serum agglutinators. Immunology. 1967 Dec;13(6):623–631. [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES